MFAP2 and neoplasm: This study showed that although MFAP2 expression was elevated in ESCC and high levels of MFAP2 were closely related to poor patient prognosis, overexpressing MFAP2 in ESCC cells only enhanced tumor growth in vivo rather than in vitro.